Table 3.
Model | Range | Coefficient | Odds Ratio | 95% CI | p |
---|---|---|---|---|---|
Biomarker Alone | |||||
Intercept | NA | 0.07 | NA | NA | 0.776 |
Biomarker | (−18.88,16.91) | 0.13 | 1.14 | (1.06, 1.21) | 0.00017 |
Clinical Variables Alone | |||||
Intercept | NA | −5.01 | NA | NA | 0.003 |
Age | (23, 79) | 0.07 | 1.07 | (1.02, 1.13) | 0.008 |
Mass Size | (0,1) | 2.19 | 8.91 | (2.08, 38.25) | 0.003 |
Lymphadenopathy | (0,1) | 2.09 | 8.12 | (1.45, 45.63) | 0.017 |
Biomarker + Clinical Variables | |||||
Intercept | NA | −4.9 | NA | NA | 0.014 |
Biomarker | (−18.88,16.91) | 0.13 | 1.13 | (1.04, 1.24) | 0.005 |
Age | (23, 79) | 0.07 | 1.07 | (1.00, 1.14) | 0.036 |
Mass Size | (0,1) | 1.85 | 6.38 | (1.39, 29.34) | 0.017 |
Lymphadenopathy | (0,1) | 2.75 | 15.69 | (2.23, 110.28) | 0.006 |